Detalhe da pesquisa
1.
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Brain
; 147(4): 1206-1215, 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38085047
2.
The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial.
Clin Immunol
; 262: 110183, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38479439
3.
Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments.
J Neurol Neurosurg Psychiatry
; 95(4): 375-383, 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37798095
4.
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 95(7): 620-625, 2024 Jun 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38242680
5.
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60.
J Neurol Neurosurg Psychiatry
; 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38453478
6.
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse.
J Neurol Neurosurg Psychiatry
; 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38744459
7.
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease.
J Neurol Neurosurg Psychiatry
; 95(6): 544-553, 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38290838
8.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38569872
9.
No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
Mult Scler
; : 13524585241240406, 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38511853
10.
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force.
Mult Scler
; 30(3): 396-418, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38140852
11.
The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.
Eur J Neurol
; 31(1): e16046, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37584176
12.
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
Brain
; 146(6): 2316-2331, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36448302
13.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37369086
14.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37414538
15.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36171104
16.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37414534
17.
An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.
Cerebellum
; 22(4): 761-775, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35761144
18.
Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis.
Mult Scler
; 29(4-5): 540-548, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36876595
19.
Prediction of relapse activity when switching to cladribine for multiple sclerosis.
Mult Scler
; 29(1): 119-129, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35894247
20.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Mult Scler
; 29(2): 221-235, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36433775